ATORVASTATIN-AS atorvastatin (as calcium) 20 mg film-coated tablet blister pack

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

atorvastatin calcium, Quantity: 20.68 mg (Equivalent: atorvastatin, Qty 20 mg)

Dostupné s:

Medis Pharma Pty Ltd

INN (Mezinárodní Name):

Atorvastatin calcium

Léková forma:

Tablet, film coated

Složení:

Excipient Ingredients: magnesium stearate; colloidal anhydrous silica; activated attapulgite; microcrystalline cellulose; pregelatinised maize starch; hyprolose; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000

Podání:

Oral

Jednotky v balení:

10, 20, 40, 50, 30

Druh předpisu:

(S4) Prescription Only Medicine

Terapeutické indikace:

As an adjunct to diet for the treatment of patients with hypercholesterolaemia. Prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy and alcoholism) should be identified and treated.,Indicated in hypertensive patients with multiple risk factors for coronary heart disease (CHD), which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic CHD (see CLINICAL TRIALS, Prevention of Cardiovascular Disease) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke. These effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.

Přehled produktů:

Visual Identification: White, oval bi-convex tablets with breakline on one side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Stav Autorizace:

Registered

Datum autorizace:

2011-09-16